OpenURL Connection Search

Select item for more details and to access through your institution.

Chronopharmacokinetics of Sumatriptan in Healthy Human Subjects.
Published in:
Journal of Pharmacy & Pharmacology, 2000, v. 52, n. 9, p. 1085, doi. 10.1211/0022357001775001
By:
- POONDRU, SRINIVASU;
- DEVARAJ, RAMBHAU;
- BOINPALLY, RAMESH R.;
- YAMASANI, MADHUSUDAN R.
Publication type:
Article
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
Published in:
2017
By:
- Leighl, Natasha B.;
- Rizvi, Naiyer A.;
- de Lima Jr., Lopes Gilberto;
- Arpornwirat, Wichit;
- Rudin, Charles M.;
- Chiappori, Alberto A.;
- Myung-Ju Ahn;
- Chow, Laura Q. M.;
- Bazhenova, Lyudmila;
- Dechaphunkul, Arunee;
- Sunpaweravong, Patrapim;
- Eaton, Keith;
- Jihong Chen;
- Medley, Sonja;
- Poondru, Srinivasu;
- Singh, Margaret;
- Steinberg, Joyce;
- Juergens, Rosalyn A.;
- Gadgeel, Shirish M.;
- de Lima, Lopes Gilberto Jr
Publication type:
journal article
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer.
Published in:
2017
By:
- Ciuleanu, Tudor-Eliade;
- Ahmed, Samreen;
- Kim, Joo-Hang;
- Mezger, Jörg;
- Park, Keunchil;
- Thomas, Michael;
- Chen, Jihong;
- Poondru, Srinivasu;
- VanTornout, Jan M;
- Whitcomb, Debbie;
- Blackhall, Fiona;
- Mezger, Jörg
Publication type:
journal article
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.
Published in:
2016
By:
- Mateo, Joaquin;
- Olmos, David;
- Dumez, Herlinde;
- Poondru, Srinivasu;
- Samberg, Nancy L;
- Barr, Sharon;
- Van Tornout, Jan M;
- Jie, Fei;
- Sandhu, Shahneen;
- Tan, Daniel S;
- Moreno, Victor;
- LoRusso, Patricia M;
- Kaye, Stan B;
- Schöffski, Patrick;
- Schöffski, Patrick
Publication type:
journal article
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.
Published in:
Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 531, doi. 10.1002/cpt.3298
By:
- Samineni, Divya;
- Venkatakrishnan, Karthik;
- Othman, Ahmed A.;
- Pithavala, Yazdi K.;
- Poondru, Srinivasu;
- Patel, Chirag;
- Vaddady, Pavan;
- Ankrom, Wendy;
- Ramanujan, Saroja;
- Budha, Nageshwar;
- Wu, Michael;
- Haddish‐Berhane, Nahor;
- Fritsch, Holger;
- Hussain, Azher;
- Kanodia, Jitendra;
- Li, Meng;
- Li, Mengyao;
- Melhem, Murad;
- Parikh, Apurvasena;
- Upreti, Vijay V.
Publication type:
Article
Mass balance, pharmacokinetics, and metabolism of linsitinib in cancer patients.
Published in:
2016
By:
- Poondru, Srinivasu;
- Chaves, Jorge;
- Yuen, Geoffrey;
- Parker, Barbara;
- Conklin, Elizabeth;
- Singh, Margaret;
- Nagata, Masanori;
- Gill, Stanley
Publication type:
journal article
Pharmacokinetics of Diethylcarbamazine after Single Oral Dose at Two Different Times of Day in Human Subjects.
Published in:
Journal of Clinical Pharmacology, 2002, v. 42, n. 3, p. 327, doi. 10.1177/009127000204200310
By:
- Bolla, Sambamoorthy;
- Boinpally, Ramesh R.;
- Poondru, Srinivasu;
- Devaraj, Rambhau;
- Jasti, Bhaskara R.
Publication type:
Article
Lack of Pharmacokinetic Interaction between Sumatriptan and Naproxen.
Published in:
Journal of Clinical Pharmacology, 2000, v. 40, n. 1, p. 99, doi. 10.1177/009127000004000113
By:
- Srinivasu, Poondru;
- Rambhau, Devaraj;
- Rao, Boinpally Ramesh;
- Rao, Yamsani Madhusudan
Publication type:
Article
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates.
Published in:
Journal of Pharmacokinetics & Pharmacodynamics, 2023, v. 50, n. 5, p. 365, doi. 10.1007/s10928-023-09867-7
By:
- Otsuka, Yukio;
- Poondru, Srinivasu;
- Bonate, Peter L.;
- Rose, Rachel H.;
- Jamei, Masoud;
- Ushigome, Fumihiko;
- Minematsu, Tsuyoshi
Publication type:
Article
Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
Published in:
Clinical Pharmacokinetics, 2024, v. 63, n. 4, p. 423, doi. 10.1007/s40262-024-01369-0
By:
- Tang, Mei;
- Garg, Amit;
- Bonate, Peter L.;
- Rosenberg, Jonathan E.;
- Matsangou, Maria;
- Kadokura, Takeshi;
- Yamada, Akihiro;
- Choules, Mary;
- Pavese, Janet;
- Nagata, Masanori;
- Tenmizu, Daisuke;
- Koibuchi, Akira;
- Heo, Nakyo;
- Wang, Lu;
- Wojtkowski, Tomasz;
- Hanley, William D.;
- Poondru, Srinivasu
Publication type:
Article
Effect of enzalutamide on PK of P‐gp and BCRP substrates in cancer patients: CYP450 induction may not always predict overall effect on transporters.
Published in:
CTS: Clinical & Translational Science, 2022, v. 15, n. 5, p. 1131, doi. 10.1111/cts.13229
By:
- Poondru, Srinivasu;
- Ghicavii, Vitalii;
- Khosravan, Reza;
- Manchandani, Pooja;
- Heo, Nakyo;
- Moy, Selina;
- Wojtkowski, Tomasz;
- Patton, Melanie;
- Haas, Gabriel P.
Publication type:
Article
A Randomized Phase II Study of AGS‐16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma.
Published in:
Oncologist, 2021, v. 26, n. 3, p. 182, doi. 10.1002/onco.13628
By:
- Kollmannsberger, Christian;
- Choueiri, Toni K.;
- Heng, Daniel Y.C.;
- George, Saby;
- Jie, Fei;
- Croitoru, Ruslan;
- Poondru, Srinivasu;
- Thompson, John A.
Publication type:
Article
Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy.
Published in:
Drug Safety, 2024, v. 47, n. 7, p. 617, doi. 10.1007/s40264-024-01415-7
By:
- Lennep, Brandon W.;
- Mack, Jesse;
- Poondru, Srinivasu;
- Hood, Elizabeth;
- Looney, Brooke D.;
- Williams, Monique;
- Bianco, Judeth J.;
- Morgans, Alicia K.
Publication type:
Article

Found: 13